{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:12:06Z","timestamp":1792026726038,"version":"4.4.0"},"reference-count":126,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003150","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T14:26:47Z","timestamp":1461076007000},"page":"e3150","source":"Crossref","is-referenced-by-count":85,"title":["Hepcidin"],"prefix":"10.1097","volume":"95","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210226","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gut.2010.214312","article-title":"Iron sensing and signalling","volume":"61","author":"Evstatiev","year":"2012","journal-title":"Gut"},{"key":"R2-15-20210226","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpeds.2015.07.013","article-title":"Iron: current landscape and efforts to address a complex issue in a complex world","volume":"167","author":"Raiten","year":"2015","journal-title":"J Pediatr"},{"key":"R3-15-20210226","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R4-15-20210226","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0268-960X(09)70003-7","article-title":"Optimizing iron chelation strategies in beta-thalassaemia major","volume":"23","author":"Porter","year":"2009","journal-title":"Blood Rev"},{"key":"R5-15-20210226","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(79)92175-5","article-title":"Iron-absorption and loading in beta-thalassemia intermedia","volume":"2","author":"Pippard","year":"1979","journal-title":"Lancet"},{"key":"R6-15-20210226","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"key":"R7-15-20210226","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3324\/haematol.2009.014399","article-title":"Hepcidin targets ferroportin for degradation in hepatocytes","volume":"95","author":"Ramey","year":"2010","journal-title":"Haematologica"},{"key":"R8-15-20210226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metab"},{"key":"R9-15-20210226","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"R10-15-20210226","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2004-08-3375","article-title":"Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia","volume":"105","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"R11-15-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu Rev Med"},{"key":"R12-15-20210226","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cmet.2012.03.018","article-title":"Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination","volume":"15","author":"Qiao","year":"2012","journal-title":"Cell Metab"},{"key":"R13-15-20210226","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.25746","article-title":"Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"R14-15-20210226","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood-2011-01-330324","article-title":"Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"R15-15-20210226","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"key":"R16-15-20210226","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23198","article-title":"Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload","volume":"50","author":"Wallace","year":"2009","journal-title":"Hepatology"},{"key":"R17-15-20210226","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/ars.2013.5819","article-title":"HJV and HFE play distinct roles in regulating hepcidin","volume":"22","author":"Wu","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"R18-15-20210226","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00109-015-1253-7","article-title":"Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin","volume":"93","author":"Kent","year":"2015","journal-title":"J Mol Med (Berl"},{"key":"R19-15-20210226","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"key":"R20-15-20210226","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1073\/pnas.0603124103","article-title":"Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6","volume":"103","author":"Truksa","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-15-20210226","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat Genet"},{"key":"R22-15-20210226","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","article-title":"A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metab"},{"key":"R23-15-20210226","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng1777","article-title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression","volume":"38","author":"Babitt","year":"2006","journal-title":"Nat Genet"},{"key":"R24-15-20210226","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1172\/JCI25049","article-title":"A mouse model of juvenile hemochromatosis","volume":"115","author":"Huang","year":"2005","journal-title":"J Clin Invest"},{"key":"R25-15-20210226","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1074\/jbc.M110.109488","article-title":"The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo","volume":"285","author":"Zhang","year":"2010","journal-title":"J Biol Chem"},{"key":"R26-15-20210226","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood-2009-11-251199","article-title":"Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis","volume":"115","author":"Lee","year":"2010","journal-title":"Blood"},{"key":"R27-15-20210226","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1021\/bi800036h","article-title":"Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domains","volume":"47","author":"Yang","year":"2008","journal-title":"Biochemistry"},{"key":"R28-15-20210226","doi-asserted-by":"crossref","first-page":"22580","DOI":"10.1074\/jbc.M109.027318","article-title":"Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"R29-15-20210226","doi-asserted-by":"crossref","first-page":"35104","DOI":"10.1074\/jbc.M112.363937","article-title":"Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage","volume":"287","author":"Enns","year":"2012","journal-title":"J Biol Chem"},{"key":"R30-15-20210226","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1157121","article-title":"The serine protease TMPRSS6 is required to sense iron deficiency","volume":"320","author":"Du","year":"2008","journal-title":"Science"},{"key":"R31-15-20210226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.130","article-title":"Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)","volume":"40","author":"Finberg","year":"2008","journal-title":"Nat Genet"},{"key":"R32-15-20210226","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2008-04-149773","article-title":"Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis","volume":"112","author":"Folgueras","year":"2008","journal-title":"Blood"},{"key":"R33-15-20210226","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cmet.2008.09.012","article-title":"The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin","volume":"8","author":"Silvestri","year":"2008","journal-title":"Cell Metab"},{"key":"R34-15-20210226","doi-asserted-by":"crossref","first-page":"e0148540","DOI":"10.1371\/journal.pone.0148540","article-title":"Effect of erythropoietin, iron deficiency and iron overload on liver matriptase-2 (TMPRSS6) protein content in mice and rats","volume":"11","author":"Frydlova","year":"2016","journal-title":"PLoS One"},{"key":"R35-15-20210226","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood-2011-04-348698","article-title":"Regulation of TMPRSS6 by BMP6 and iron in human cells and mice","volume":"118","author":"Meynard","year":"2011","journal-title":"Blood"},{"key":"R36-15-20210226","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1074\/jbc.M110.173096","article-title":"Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis","volume":"286","author":"Lakhal","year":"2011","journal-title":"J Biol Chem"},{"key":"R37-15-20210226","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1074\/jbc.M114.611913","article-title":"Low intracellular iron increases the stability of matriptase-2","volume":"290","author":"Zhao","year":"2015","journal-title":"J Biol Chem"},{"key":"R38-15-20210226","doi-asserted-by":"crossref","first-page":"e82127","DOI":"10.1371\/journal.pone.0082127","article-title":"Inflammation regulates TMPRSS6 expression via STAT5","volume":"8","author":"Meynard","year":"2013","journal-title":"PLoS One"},{"key":"R39-15-20210226","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-02-411470","article-title":"Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1\/5\/8 signaling","volume":"120","author":"Besson-Fournier","year":"2012","journal-title":"Blood"},{"key":"R40-15-20210226","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/en.2015-1747","article-title":"Activin B induces noncanonical SMAD1\/5\/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice","volume":"157","author":"Canali","year":"2016","journal-title":"Endocrinology"},{"key":"R41-15-20210226","doi-asserted-by":"crossref","first-page":"30637","DOI":"10.1074\/jbc.M115.689190","article-title":"Commensal bacteria-induced interleukin 1beta (IL-1beta) secreted by macrophages up-regulates hepcidin expression in hepatocytes by activating the bone morphogenetic protein signaling pathway","volume":"290","author":"Shanmugam","year":"2015","journal-title":"J Biol Chem"},{"key":"R42-15-20210226","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2016.02.001","article-title":"Homocysteine upregulates hepcidin expression through BMP6\/SMAD signaling pathway in hepatocytes","volume":"471","author":"Luo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"R43-15-20210226","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"R44-15-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2006-07-033969","article-title":"STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation","volume":"109","author":"Verga Falzacappa","year":"2007","journal-title":"Blood"},{"key":"R45-15-20210226","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R46-15-20210226","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000132","article-title":"New insights into iron regulation and erythropoiesis","volume":"22","author":"Kim","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"R47-15-20210226","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"key":"R48-15-20210226","first-page":"184","article-title":"Growth differentiation factor 15 in erythroid health and disease","volume":"17","author":"Tanno","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"R49-15-20210226","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajh.23649","article-title":"Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15","volume":"89","author":"Fertrin","year":"2014","journal-title":"Am J Hematol"},{"key":"R50-15-20210226","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2008-12-195503","article-title":"Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells","volume":"114","author":"Tanno","year":"2009","journal-title":"Blood"},{"key":"R51-15-20210226","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"R52-15-20210226","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"key":"R53-15-20210226","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1210\/en.2011-2045","article-title":"17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site","volume":"153","author":"Yang","year":"2012","journal-title":"Endocrinology"},{"key":"R54-15-20210226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.gene.2012.09.060","article-title":"Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element","volume":"511","author":"Hou","year":"2012","journal-title":"Gene"},{"key":"R55-15-20210226","doi-asserted-by":"crossref","first-page":"e40465","DOI":"10.1371\/journal.pone.0040465","article-title":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes","volume":"7","author":"Ikeda","year":"2012","journal-title":"PLoS One"},{"key":"R56-15-20210226","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI83831","article-title":"Progesterone receptor membrane component-1 regulates hepcidin biosynthesis","volume":"126","author":"Li","year":"2016","journal-title":"J Clin Invest"},{"key":"R57-15-20210226","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4254\/wjh.v8.i4.211","article-title":"Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver","volume":"8","author":"Lu","year":"2016","journal-title":"World J Hepatol"},{"key":"R58-15-20210226","first-page":"7","article-title":"Hepcidin and iron metabolism in pregnancy: correlation with smoking and birth weight and length.","volume":"1-","author":"Chelchowska","year":"2016","journal-title":"Biol Trace Elem Res"},{"key":"R59-15-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2013.1.1","article-title":"Iron and hepcidin: a story of recycling and balance","volume":"2013","author":"Camaschella","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R60-15-20210226","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1182\/blood-2006-09-048868","article-title":"Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin","volume":"109","author":"Gardenghi","year":"2007","journal-title":"Blood"},{"key":"R61-15-20210226","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1182\/blood-2006-07-036186","article-title":"Physiologic systemic iron metabolism in mice deficient for duodenal Hfe","volume":"109","author":"Vujic Spasic","year":"2007","journal-title":"Blood"},{"key":"R62-15-20210226","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/cc9408","article-title":"Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study","volume":"15","author":"van Eijk","year":"2011","journal-title":"Crit Care"},{"key":"R63-15-20210226","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"J Clin Invest"},{"key":"R64-15-20210226","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3324\/haematol.2009.013136","article-title":"Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin","volume":"95","author":"Ashby","year":"2010","journal-title":"Haematologica"},{"key":"R65-15-20210226","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/gutjnl-2013-305317","article-title":"Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB","volume":"63","author":"Sonnweber","year":"2014","journal-title":"Gut"},{"key":"R66-15-20210226","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/leu.2011.95","article-title":"The role of Smad signaling in hematopoiesis and translational hematology","volume":"25","author":"Blank","year":"2011","journal-title":"Leukemia"},{"key":"R67-15-20210226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm.3468","article-title":"An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia","volume":"20","author":"Dussiot","year":"2014","journal-title":"Nat Med"},{"key":"R68-15-20210226","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature13614","article-title":"HSP70 sequestration by free alpha-globin promotes ineffective erythropoiesis in beta-thalassaemia","volume":"514","author":"Arlet","year":"2014","journal-title":"Nature"},{"key":"R69-15-20210226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1051\/medsci\/20153101002","article-title":"HSP70 regulates ineffective erythropoiesis in beta-thalassaemia","volume":"31","author":"Arlet","year":"2015","journal-title":"Med Sci (Paris"},{"key":"R71-15-20210226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.3814","article-title":"Anemia: progress in molecular mechanisms and therapies","volume":"21","author":"Sankaran","year":"2015","journal-title":"Nat Med"},{"key":"R72-15-20210226","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.hoc.2014.04.005","article-title":"Anemia of inflammation","volume":"28","author":"Nemeth","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"R73-15-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpeds.2015.07.015","article-title":"Pathophysiology of iron homeostasis during inflammatory states","volume":"167","author":"Cherayil","year":"2015","journal-title":"J Pediatr"},{"key":"R74-15-20210226","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00535-009-0159-y","article-title":"STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo","volume":"45","author":"Sakamori","year":"2010","journal-title":"J Gastroenterol"},{"key":"R75-15-20210226","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.1202716","article-title":"IL-22 regulates iron availability in vivo through the induction of hepcidin","volume":"191","author":"Smith","year":"2013","journal-title":"J Immunol"},{"key":"R76-15-20210226","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2011-04-351957","article-title":"Hepcidin regulation by innate immune and infectious stimuli","volume":"118","author":"Armitage","year":"2011","journal-title":"Blood"},{"key":"R77-15-20210226","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2013.07.011","article-title":"Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases","volume":"25","author":"Poggiali","year":"2014","journal-title":"Eur J Intern Med"},{"key":"R78-15-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ped.12395","article-title":"Novel mutation in the TMPRSS6 gene with iron-refractory iron deficiency anemia","volume":"56","author":"Kodama","year":"2014","journal-title":"Pediatr Int"},{"key":"R79-15-20210226","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.12147","article-title":"A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA)","volume":"160","author":"Jaspers","year":"2013","journal-title":"Br J Haematol"},{"key":"R80-15-20210226","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3324\/haematol.2015.133348","article-title":"Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia","volume":"101","author":"Casu","year":"2016","journal-title":"Haematologica"},{"key":"R81-15-20210226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cld.2014.09.011","article-title":"Diagnosis and management of hereditary hemochromatosis","volume":"19","author":"Salgia","year":"2015","journal-title":"Clin Liver Dis"},{"key":"R82-15-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.24231","article-title":"Thalassemia 2016: modern medicine battles an ancient disease","volume":"91","author":"Rund","year":"2015","journal-title":"Am J Hematol"},{"key":"R83-15-20210226","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3324\/haematol.2012.075515","article-title":"Iron refractory iron deficiency anemia","volume":"98","author":"De Falco","year":"2013","journal-title":"Haematologica"},{"key":"R84-15-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1150","article-title":"Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis","volume":"34","author":"Nicolas","year":"2003","journal-title":"Nat Genet"},{"key":"R85-15-20210226","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2362.2010.02291.x","article-title":"Hepcidin treatment in Hfe\u2212\/\u2212 mice diminishes plasma iron without affecting erythropoiesis","volume":"40","author":"Moran-Jimenez","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R86-15-20210226","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1172\/JCI57693","article-title":"Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload","volume":"121","author":"Preza","year":"2011","journal-title":"J Clin Invest"},{"key":"R87-15-20210226","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood-2012-07-440743","article-title":"Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis","volume":"120","author":"Ramos","year":"2012","journal-title":"Blood"},{"key":"R88-15-20210226","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bmcl.2014.12.094","article-title":"Thiol-derivatized mini-hepcidins retain biological activity","volume":"25","author":"Fung","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"R89-15-20210226","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.bmcl.2015.03.012","article-title":"Small cyclic agonists of iron regulatory hormone hepcidin","volume":"25","author":"Chua","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"R90-15-20210226","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/hep.26490","article-title":"The small molecule, genistein, increases hepcidin expression in human hepatocytes","volume":"58","author":"Zhen","year":"2013","journal-title":"Hepatology"},{"key":"R91-15-20210226","doi-asserted-by":"crossref","first-page":"e70199","DOI":"10.1371\/journal.pone.0070199","article-title":"Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo","volume":"8","author":"Byrne","year":"2013","journal-title":"PLoS One"},{"key":"R92-15-20210226","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1152\/ajpgi.00324.2014","article-title":"The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro","volume":"308","author":"Alkhateeb","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R93-15-20210226","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcmd.2014.06.002","article-title":"A chemical screen identifies small molecules that regulate hepcidin expression","volume":"53","author":"Gaun","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"R95-15-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000243792","article-title":"Role of matriptase-2 (TMPRSS6) in iron metabolism","volume":"122","author":"Lee","year":"2009","journal-title":"Acta Haematol"},{"key":"R96-15-20210226","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2012-01-401885","article-title":"Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia","volume":"119","author":"Nai","year":"2012","journal-title":"Blood"},{"key":"R97-15-20210226","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1172\/JCI66969","article-title":"Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice","volume":"123","author":"Guo","year":"2013","journal-title":"J Clin Invest"},{"key":"R98-15-20210226","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2012-09-453977","article-title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-\/-) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia","volume":"121","author":"Schmidt","year":"2013","journal-title":"Blood"},{"key":"R99-15-20210226","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23934","article-title":"Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia","volume":"90","author":"Schmidt","year":"2015","journal-title":"Am J Hematol"},{"key":"R101-15-20210226","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2010.07.044","article-title":"BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice","volume":"139","author":"Corradini","year":"2010","journal-title":"Gastroenterology"},{"key":"R102-15-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00086","article-title":"Hepcidin antagonists for potential treatments of disorders with hepcidin excess","volume":"5","author":"Poli","year":"2014","journal-title":"Front Pharmacol"},{"key":"R103-15-20210226","first-page":"41","article-title":"Iron mobilization and pharmacodynic marker measurements in non-human primates following administration of Prs-080: a novel and highly specific anti-hepcidin therapeutic","volume":"88","author":"Hohlbaum","year":"2013","journal-title":"Am J Hematol"},{"key":"R104-15-20210226","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2012-09-456756","article-title":"The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys","volume":"121","author":"Schwoebel","year":"2013","journal-title":"Blood"},{"key":"R105-15-20210226","first-page":"225","article-title":"Single and repeated dose first-in-human study with the anti-hepcidin Spiegelmer Nox-H94","volume":"88","author":"Riecke","year":"2013","journal-title":"Am J Hematol"},{"key":"R106-15-20210226","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2014-03-559484","article-title":"Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans","volume":"124","author":"van Eijk","year":"2014","journal-title":"Blood"},{"key":"R107-15-20210226","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drudis.2014.09.004","article-title":"Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(R) therapeutics","volume":"20","author":"Vater","year":"2015","journal-title":"Drug Discov Today"},{"key":"R108-15-20210226","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"R109-15-20210226","doi-asserted-by":"crossref","first-page":"24783","DOI":"10.1074\/jbc.M110.130286","article-title":"Soluble repulsive guidance molecule c\/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression","volume":"285","author":"Nili","year":"2010","journal-title":"J Biol Chem"},{"key":"R110-15-20210226","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","article-title":"Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats","volume":"118","author":"Theurl","year":"2011","journal-title":"Blood"},{"key":"R111-15-20210226","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","article-title":"Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors","volume":"18","author":"Cuny","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"R112-15-20210226","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1182\/blood-2010-10-313064","article-title":"Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation","volume":"117","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"key":"R113-15-20210226","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/ndt\/gfs584","article-title":"A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R114-15-20210226","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1208\/s12248-015-9770-4","article-title":"Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation","volume":"17","author":"Boser","year":"2015","journal-title":"AAPS J"},{"key":"R115-15-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-19-83","article-title":"Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter","volume":"19","author":"Salama","year":"2012","journal-title":"J Biomed Sci"},{"key":"R116-15-20210226","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/rheumatology\/kes381","article-title":"Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial","volume":"52","author":"Doyle","year":"2013","journal-title":"Rheumatology (Oxford"},{"key":"R117-15-20210226","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","article-title":"Interleukin-6 induces hepcidin expression through STAT3","volume":"108","author":"Wrighting","year":"2006","journal-title":"Blood"},{"key":"R118-15-20210226","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00296-009-1075-4","article-title":"Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production","volume":"30","author":"Hashizume","year":"2010","journal-title":"Rheumatol Int"},{"key":"R119-15-20210226","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","article-title":"Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease","volume":"116","author":"Song","year":"2010","journal-title":"Blood"},{"key":"R120-15-20210226","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/rheumatology\/ker223","article-title":"Risk of infections in rheumatoid arthritis patients treated with tocilizumab","volume":"51","author":"Lang","year":"2012","journal-title":"Rheumatology (Oxford"},{"key":"R121-15-20210226","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/BOR.0b013e3282f05c6d","article-title":"Targets of anticytokine therapy and the risk of infections in humans and mice","volume":"19","author":"van de Vosse","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"R122-15-20210226","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.3748\/wjg.v17.i45.5032","article-title":"AG490: an inhibitor of hepcidin expression in vivo","volume":"17","author":"Zhang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R123-15-20210226","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","article-title":"Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo","volume":"117","author":"Poli","year":"2011","journal-title":"Blood"},{"key":"R124-15-20210226","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2013-07-515221","article-title":"Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo","volume":"123","author":"Poli","year":"2014","journal-title":"Blood"},{"key":"R125-15-20210226","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2013040355","article-title":"Suppression of iron-regulatory hepcidin by vitamin D","volume":"25","author":"Bacchetta","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R126-15-20210226","doi-asserted-by":"crossref","first-page":"75568","DOI":"10.1371\/journal.pone.0075568","article-title":"A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease","volume":"8","author":"Fujiwara","year":"2013","journal-title":"PLoS One"},{"key":"R127-15-20210226","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/mol.112.083428","article-title":"High-throughput screening of small molecules identifies hepcidin antagonists","volume":"83","author":"Fung","year":"2013","journal-title":"Mol Pharmacol"},{"key":"R128-15-20210226","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3945\/jn.113.174201","article-title":"Screening identifies the Chinese medicinal plant caulis spatholobi as an effective HAMP expression inhibitor","volume":"143","author":"Guan","year":"2013","journal-title":"J Nutr"},{"key":"R129-15-20210226","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/acel.12052","article-title":"Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells","volume":"12","author":"Guo","year":"2013","journal-title":"Aging Cell"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:20:28Z","timestamp":1620958828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201604050-00015"}},"subtitle":["A Promising Therapeutic Target for Iron Disorders A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":126,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003150","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}